Brainsway (BWAY) Cash from Investing Activities (2018 - 2026)
Brainsway's (BWAY) quarterly Cash from Investing Activities came in at -$9.3 million in Q1 2026, down 374.42% YoY from $3.4 million in Q1 2025, and down 802.9% on a QoQ basis from -$1.0 million in Q4 2025.
Brainsway (BWAY) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has 9 years of Cash from Investing Activities data on file, last reported at -$9.3 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 374.42% year-over-year to -$9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.9 million (down 185.54% YoY) and the FY2025 annual result came in at -$17.5 million, down 157.62% from the prior year.
- Cash from Investing Activities declined to -$9.3 million in Q1 2026, from -$1.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $40.8 million in Q2 2022 to a low of -$35.5 million in Q4 2023.
- A 5-year average of $485294.1 and a median of -$710000.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities sank 8403.51% — and 2024, when it jumped 2363.27%.
- Tracing BWAY's Cash from Investing Activities over 5 years: stood at $427000.0 in 2022, then slumped by 8403.51% to -$35.5 million in 2023, then jumped by 94.8% to -$1.8 million in 2024, then soared by 43.95% to -$1.0 million in 2025, then sank by 802.9% to -$9.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$9.3 million (Q1 2026), -$1.0 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Brainsway | 567.80 Mn | 504.63 Mn | 12.77 Mn | -2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.33 Mn |
| Mar 31, 2026 | -9.33 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Jun 30, 2025 | -15.86 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Mar 31, 2025 | -1.97 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Sep 30, 2024 | -1.33 Mn |
| Jun 30, 2024 | 34.20 Mn |
| Jun 30, 2024 | 34.20 Mn |
| Mar 31, 2024 | -710,000.00 |
| Mar 31, 2024 | -710,000.00 |
| Dec 31, 2023 | -35.46 Mn |
| Dec 31, 2023 | -35.46 Mn |